FDA Inspection
Amoli Organics (A Division of Umedica Laboratories Pvt Ltd)Amoli Organics (A Division of Umedica Laboratories Pvt Ltd) – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns Amoli Organics (A Division of Umedica Laboratories Pvt Ltd), with an inspection on July 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 20, 2018
- Product Type
- Drugs
View Company Profile
ID · d7922de8-2c56-4ce2-badc-b2494f27f075
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1065141
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Amoli Organics (A Division of Umedica Laboratories Pvt Ltd)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 4, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amoli Organics (A Division of Umedica Laboratories Pvt Ltd)
- FDA Inspection 1231931 - 2024-03-04
- FDA Inspection 1018720 - 2017-03-31
- FDA Inspection 957768 - 2016-02-12
- FDA Inspection 878346 - 2014-04-24
- FDA Inspection 684841 - 2010-09-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.